Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FYX-051 in hyperuricemic patients with moderate renal insufficiency
jRCT2080221136Phase 3
- Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hyperuricemia and gout comparing FYX-051 with Placebo (2 arms).
02
Drugs
topiroxostat
03
Conditions
hyperuricemiagout
Beyond the preview
Go deeper on jRCT2080221136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221136.